News
The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.
The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
Vinay Prasad, a professor who until earlier this year headed a cancer-drugs and health-policy lab at UC San Francisco, ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
13hOpinion
The New Republic on MSNTrump Manages to Be Racist While Admitting He’s Wrecking Farms
Trump appeared to acknowledge in the interview that his ruthless mass deportation campaign is hurting farms, which rely on ...
8hOpinion
The New Republic on MSNIs Trump About to Drag Joe Rogan Into the Epstein Files Debacle?
The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
8h
Money Talks News on MSNPopular Food Coloring Gets FDA Boot Over Cancer Concerns
Ozzy Osbourne’s cause of death revealed after rock legend’s funeral My Wife Of 45 Years Died. I Thought I Truly Knew Her — ...
From tariffs to drug pricing to the FDA, biopharma CEOs find themselves pulled into policy discussions on this year’s second quarter earnings calls.
9h
Money Talks News on MSNFDA Study Links Low-Dose CBD to Liver Damage in Some Healthy Adults
FDA clinical trial reveals CBD may cause liver enzyme elevation in 5% of users, with women showing higher vulnerability than men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results